TIDMEDEN

RNS Number : 2069G

Eden Research plc

23 July 2021

23 July 2021

Eden Research plc

("Eden" or "Company)

Grant of Awards under Long-Term Incentive Plan

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in global crop protection, animal health and consumer products industries, confirms the grant of options under the Company's recently implemented Long Term Incentive Plan ("LTIP") to Sean Smith, Chief Executive Officer, and Alex Abrey, Chief Finance Officer (together the "Executives"), as follows:

Following the grant under the new LTIP in respect of prior years, as announced on 1 April 2021 where all outstanding grants under the previous LTIP scheme were cancelled, the Company has now made a 2021 grant in order to ensure continuity of long term incentive of options over 7,183,784 new Ordinary Shares in Eden ("the Options"), at a strike price of 10.37p each, in the amounts of 4,102,703 awarded to Sean Smith and 3,081,081 awarded to Alex Abrey.

The Options expire on 31 July 2025 and vest as follows:

1/3 upon grant

1/3 12 months from the date of grant

1/3 24 months from the date of grant

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

For further information contact:

 
                                                www.edenresearch.com 
   Eden Research plc 
 Sean Smith 
  Alex Abrey                                    01285 359 555 
 
   Cenkos Securities plc (Nominated advisor 
   and broker) 
 Giles Balleny / Camilla Hume/ Mark Connelly 
  (corporate finance) 
  Michael Johnson (sales)                       020 7397 8900 
 
   Hawthorn Advisors (Financial PR) 
 Lorna Cobbett / Victoria Ainsworth             eden@hawthornadvisors.com 
 
 
 1    Details of the person discharging managerial responsibilities / person closely associated 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                           Sean Smith 
---  -------------------------------------------------------------  -------------------------------- 
 2    Reason for the notification 
---  ----------------------------------------------------------------------------------------------- 
 a)   Position/status                                                Chief Executive Officer 
---  -------------------------------------------------------------  -------------------------------- 
 b)   Initial notification /Amendment                                Initial Notification 
---  -------------------------------------------------------------  -------------------------------- 
 3    Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                           Eden Research plc 
---  -------------------------------------------------------------  -------------------------------- 
 b)   LEI                                                            213800ZWTYTVQQSM3J85 
---  -------------------------------------------------------------  -------------------------------- 
 4    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
---  ----------------------------------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument    Ordinary shares of 1 pence each 
       Identification code 
 
                                                                      GB0001646941 
---  -------------------------------------------------------------  -------------------------------- 
 b)   Nature of the transaction                                      Grant of options 
---  -------------------------------------------------------------  -------------------------------- 
 c)   Price(s) and volume(s)                                          Price(s)   Volume(s) 
                                                                      ---------  ---------- 
                                                                       10.37p     4,102,703 
                                                                      ---------  ---------- 
---  -------------------------------------------------------------  -------------------------------- 
 d)   Aggregated information 
       - Aggregated volume 
       - Price                                                         N/A 
---  -------------------------------------------------------------  -------------------------------- 
 e)   Date of the transaction                                        22 July 2021 
---  -------------------------------------------------------------  -------------------------------- 
 f)   Place of the transaction                                       Outside of trading venue 
---  -------------------------------------------------------------  -------------------------------- 
 
 
 1    Details of the person discharging managerial responsibilities / person closely associated 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                           Alex Abrey 
---  -------------------------------------------------------------  -------------------------------- 
 2    Reason for the notification 
---  ----------------------------------------------------------------------------------------------- 
 a)   Position/status                                                Chief Financial Officer 
---  -------------------------------------------------------------  -------------------------------- 
 b)   Initial notification /Amendment                                Initial Notification 
---  -------------------------------------------------------------  -------------------------------- 
 3    Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                           Eden Research plc 
---  -------------------------------------------------------------  -------------------------------- 
 b)   LEI                                                            213800ZWTYTVQQSM3J85 
---  -------------------------------------------------------------  -------------------------------- 
 4    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
---  ----------------------------------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument    Ordinary shares of 1 pence each 
       Identification code 
 
                                                                      GB0001646941 
---  -------------------------------------------------------------  -------------------------------- 
 b)   Nature of the transaction                                      Grant of options 
---  -------------------------------------------------------------  -------------------------------- 
 c)   Price(s) and volume(s)                                          Price(s)   Volume(s) 
                                                                      ---------  ---------- 
                                                                       10.37p     3,081,081 
                                                                      ---------  ---------- 
---  -------------------------------------------------------------  -------------------------------- 
 d)   Aggregated information 
       - Aggregated volume 
       - Price                                                         N/A 
---  -------------------------------------------------------------  -------------------------------- 
 e)   Date of the transaction                                        22 July 2021 
---  -------------------------------------------------------------  -------------------------------- 
 f)   Place of the transaction                                       Outside of trading venue 
---  -------------------------------------------------------------  -------------------------------- 
 
 
 
 

Notes to Editors:

Eden Research is an AIM quoted company that develops and supplies breakthrough biopesticide products and natural, plastic-free microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden's Sustaine(R) encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally derived, plastic-free, biodegradable micro-spheres derived from yeast extract. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Eden has numerous patents and a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. Eden was admitted to trading on AIM in May 2012.

For more information about Eden, please visit: www.edenresearch.com.

, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSEIFWEEFSEFW

(END) Dow Jones Newswires

July 23, 2021 02:00 ET (06:00 GMT)

Eden Research (LSE:EDEN)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Eden Research.
Eden Research (LSE:EDEN)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Eden Research.